Table 3 Prevalence of phenotypic AMR and ESBL (phenotype and genotype) among plasmid replicon types of 72 APEC isolates (n)
Replicon (n) | Phenotypic AMR | β-Lactamase/ESBL | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SXT (63) | TE (63) | ENF (59) | FLO (41) | NEO (35) | FDZ (23) | GEN (10) | AMC (10) | CFZ (3) | MDR (63) | Phenotype (24) | blaTEM (44) | blaCTX (23) | blaOXA (1) | |
B/O (22) | 18 | 19 | 17 | 10 | 12 | 8 | 2 | 4 | 1 | 17 | 5 | 12 | 5 | 1 |
FIC (20) | 16 | 17 | 15 | 6N | 3N | 8 | 1 | 2 | 2 | 15 | 10 | 13 | 11P | 0 |
A/C (13) | 11 | 10 | 9 | 7 | 11P | 4 | 1 | 1 | 0 | 11 | 2 | 8 | 0N | 0 |
P (47) | 43 | 42 | 42P | 25 | 22 | 15 | 10P | 6 | 3 | 42 | 18 | 31 | 16 | 1 |
K/B (21) | 18 | 18 | 18 | 15 | 12 | 5 | 6 | 4 | 0 | 18 | 7 | 14 | 6 | 1 |
FIA (13) | 10 | 10 | 8N | 8 | 8 | 5 | 1 | 0 | 0 | 9N | 1N | 8 | 1N | 0 |
FIB (21) | 19 | 20 | 18 | 14 | 13 | 8 | 4 | 2 | 1 | 20 | 4 | 11 | 3 | 0 |
I1 (42) | 38 | 35 | 37 | 25 | 20 | 12 | 9P | 6 | 2 | 37 | 18P | 32P | 17 | 1 |
Frep (1) | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
HI1 (4) | 3 | 3 | 3 | 3 | 3 | 1 | 0 | 0 | 0 | 4 | 0 | 3 | 0 | 0 |
N (2) | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 0 |
HI2 (14) | 14 | 13 | 13 | 9 | 7 | 4 | 0 | 5P | 2 | 13 | 5 | 8 | 7 | 0 |
L/M (3) | 1N | 1N | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1N | 1 | 2 | 2 | 0 |